On the Record · Novavax
Novavax competitors, on the record
The companies Novavax names as competitors in its annual reports, 2023 to 2025, and the companies that name Novavax, each with the sentence and the filing.
Who Novavax names
| Company | Named in |
|---|---|
| Moderna | 2025 |
| Pfizer | 2025 |
In its own words
Moderna, Pfizer
Word for word“Several competitors are working on developing seasonal influenza vaccines using different technologies than those in existing marketed vaccines, the most notable being mRNA from companies including Moderna and Pfizer.” 10-K for 2025
Who names Novavax
Companies whose own annual reports name Novavax as a competitor.
Word for word“A number of competitors currently have programs to develop COVID-19 vaccine candidates, including vaccines developed by Moderna, Inc. and Novavax, Inc .” 20-F for 2025
Word for word“We also compete against other vaccines, including Sanofi and Novavax’s.” 10-K for 2025
Read from Novavax’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.